Kingsview Wealth Management LLC Acquires Shares of 863 Arthur J. Gallagher & Co. (NYSE:AJG)Kargil, Nov 23: Union Minister of Power, Housing, and Urban Affairs Manohar Lal Khattar Saturday concluded his three-day visit to Ladakh flagging off National Thermal Power Corporation (NTPC)’s green hydrogen buses and visiting the waste-to-art sculpture site in Leh. Khattar had arrived in Leh on Thursday for a three-day visit, his maiden after assuming office. During his visit, he laid the foundation and inaugurated several projects. Khattar also met the Lieutenant Governor of Ladakh and senior officials of the Ladakh administration and reviewed several projects and schemes under his ministry. On the last day of his tour, he flagged off the NTPC’s green hydrogen fuel cell buses as part of the Green Hydrogen Mobility Project, Leh. The project is the world’s highest altitude (3650m MSL) green hydrogen mobility project. After the flag-off, Khattar travelled 12 km in one of the H2 buses from the H2 filling station to the Leh airport. He congratulated NTPC for its contribution to the energy security and decarbonisation efforts of the country through the adoption of hydrogen technologies at various fronts like mobility, blending with PNG, green methanol and its overall thrust on renewable energy. Khattar also inaugurated NTPC’s Green Hydrogen Mobility Project in Leh, featuring a hydrogen fueling station, a 1.7 MW solar plant, and five fuel cell buses operating at 11,562 feet. This marks India’s first hydrogen bus deployment on public roads. NTPC targets 60 GW renewable energy capacity by 2032 and leadership in green hydrogen and energy storage. This station would mitigate the carbon emissions of approximately 350 metric tons a year and contribute 230 metric tons per year of pure oxygen into the atmosphere which is equal to the planting of approximately 13,000 trees. Earlier Khattar visited the waste-to-art sculptures site in Leh. The sculptures at the site have been created out of waste and junk material and installed during the Y-20 Summit in 2023.
Intech Investment Management LLC grew its stake in shares of Southwest Gas Holdings, Inc. ( NYSE:SWX – Free Report ) by 112.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,849 shares of the utilities provider’s stock after buying an additional 5,740 shares during the period. Intech Investment Management LLC’s holdings in Southwest Gas were worth $800,000 at the end of the most recent reporting period. A number of other hedge funds also recently made changes to their positions in the stock. O Shaughnessy Asset Management LLC purchased a new position in Southwest Gas during the first quarter valued at approximately $202,000. Price T Rowe Associates Inc. MD lifted its stake in shares of Southwest Gas by 1.9% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 56,585 shares of the utilities provider’s stock valued at $4,308,000 after buying an additional 1,079 shares in the last quarter. Public Employees Retirement System of Ohio bought a new position in Southwest Gas in the 1st quarter worth $115,000. GAMMA Investing LLC increased its stake in Southwest Gas by 154.8% in the 2nd quarter. GAMMA Investing LLC now owns 428 shares of the utilities provider’s stock worth $30,000 after buying an additional 260 shares in the last quarter. Finally, V Square Quantitative Management LLC raised its holdings in Southwest Gas by 8.8% during the second quarter. V Square Quantitative Management LLC now owns 4,104 shares of the utilities provider’s stock valued at $289,000 after acquiring an additional 332 shares during the period. 92.77% of the stock is currently owned by institutional investors. Wall Street Analyst Weigh In A number of research firms have recently weighed in on SWX. JPMorgan Chase & Co. dropped their price objective on Southwest Gas from $78.00 to $70.00 and set a “neutral” rating for the company in a research note on Thursday, August 15th. Wells Fargo & Company upped their price target on Southwest Gas from $74.00 to $78.00 and gave the stock an “equal weight” rating in a research note on Wednesday, September 25th. Insider Buying and Selling In related news, major shareholder Carl C. Icahn sold 1,390,000 shares of Southwest Gas stock in a transaction dated Tuesday, November 19th. The stock was sold at an average price of $76.74, for a total value of $106,668,600.00. Following the completion of the transaction, the insider now owns 9,632,604 shares in the company, valued at approximately $739,206,030.96. This trade represents a 12.61 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink . 0.39% of the stock is currently owned by company insiders. Southwest Gas Stock Down 0.1 % Shares of SWX stock opened at $78.24 on Friday. The stock has a market cap of $5.61 billion, a P/E ratio of 31.55, a PEG ratio of 4.13 and a beta of 0.38. The company’s fifty day simple moving average is $74.93 and its two-hundred day simple moving average is $73.75. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 1.21. Southwest Gas Holdings, Inc. has a 52 week low of $57.55 and a 52 week high of $80.29. Southwest Gas ( NYSE:SWX – Get Free Report ) last posted its earnings results on Wednesday, November 6th. The utilities provider reported $0.09 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.02. The company had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.12 billion. Southwest Gas had a return on equity of 5.99% and a net margin of 3.44%. The firm’s revenue for the quarter was down 7.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.10 earnings per share. Analysts predict that Southwest Gas Holdings, Inc. will post 3.16 EPS for the current fiscal year. Southwest Gas Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Tuesday, February 18th will be issued a $0.62 dividend. This represents a $2.48 dividend on an annualized basis and a dividend yield of 3.17%. The ex-dividend date of this dividend is Tuesday, February 18th. Southwest Gas’s dividend payout ratio (DPR) is presently 100.00%. About Southwest Gas ( Free Report ) Southwest Gas Holdings, Inc, through its subsidiaries, distributes and transports natural gas in Arizona, Nevada, and California. The company operates through Natural Gas Distribution, Utility Infrastructure Services, and Pipeline and Storage segments. It also provides trenching, installation, and replacement of underground pipes, as well as maintenance services for energy distribution systems. Further Reading Five stocks we like better than Southwest Gas The How And Why of Investing in Oil Stocks The Latest 13F Filings Are In: See Where Big Money Is Flowing What is the Dow Jones Industrial Average (DJIA)? 3 Penny Stocks Ready to Break Out in 2025 3 Warren Buffett Stocks to Buy Now FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential Want to see what other hedge funds are holding SWX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Southwest Gas Holdings, Inc. ( NYSE:SWX – Free Report ). Receive News & Ratings for Southwest Gas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Southwest Gas and related companies with MarketBeat.com's FREE daily email newsletter .
PLEASANTON, Calif. , Dec. 23, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx products sold by Bruker Corporation (Nasdaq: BRKR), which acquired the product line from NanoString Technologies. To minimize the risk of disruption to ongoing research, 10x Genomics requested a carve-out for GeoMx users who installed an instrument prior to the trial in November 2023 . The injunction, which the Court said it will enter in January 2025 , is expected to prohibit Bruker from making, using, selling or offering to sell in the United States its GeoMx Digital Spatial Profiler and associated instruments, reagents and services for RNA and protein detection. At the request of 10x Genomics, the injunction will not block ongoing research by researchers who installed a GeoMx instrument prior to November 18, 2023 . Such customers can continue to purchase GeoMx reagents for use with existing GeoMx instruments for purposes of continuing their ongoing research. The Court found that making such an exception for ongoing research strikes a "workable balance between protecting the patentee's rights and protecting the public from the injunction's adverse effects." In addition, the Court affirmed the $31 million damages awarded by the November 2023 jury verdict, as well as supplemental damages and interest that will be added to the total damages when final judgment is entered. "Today's decision helps to safeguard our decade-long investment in innovation and ensures we can continue to develop groundbreaking technologies that help our customers revolutionize science," said Eric Whitaker , Chief Legal Officer at 10x Genomics. "10x exists to fuel scientific progress – not stifle it – and that is why we've done our utmost to ensure this injunction was structured to protect both our intellectual property and existing GeoMx customers' ongoing research." The Court recognized the harm NanoString's infringing conduct caused 10x when it wrote in its ruling, "Having been careful not to license its technology, 10x suffers when it proclaims itself as an innovator in spatial genomics but a competitor is using the same innovative, patented technology." Today's Court decision follows a November 2023 jury verdict that found that NanoString's GeoMx products willfully infringed seven patents exclusively licensed to 10x Genomics by Prognosys. During the trial, the jury heard testimony from the sole inventor of the patents, Illumina co-founder Mark Chee , and NanoString CEO Brad Gray and NanoString CSO Joe Beechem. After hearing all of the evidence, the jury determined that all seven patents had been infringed by NanoString, that each patent was valid, that NanoString willfully infringed those patents and that monetary damages were owed to 10x for the infringement of all seven patents. In affirming the jury's finding that NanoString willfully infringed, the Court relied on the evidence showing that NanoString knew or was willfully blind that its acts would cause infringement of 10x's rights. The asserted patents in Case No. 21-cv-653-MFK include (a) U.S. Patent No. 10,472,669; (b) U.S. Patent No. 10,961,566; (c) U.S. Patent No. 10,983,113; (d) U.S. Patent No. 10,996,219; (e) U.S. Patent No. 11,001,878; (f) U.S. Patent No. 11,008,607 and (g) U.S. Patent No. 11,293,917. About 10x Genomics 10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter) . Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. All statements included in this press release, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "might," "will," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "see," "estimate," "predict," "potential," "would," "likely," "seek" or "continue" or the negatives of these terms or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include statements regarding litigation and remedies as well as possible outcomes of litigation. These forward-looking statements do not reflect that our success will depend on our ability to obtain, maintain and protect our intellectual property rights, intellectual property litigation could be expensive, time-consuming, unsuccessful and could interfere with our ability to develop, manufacture and commercialize our products or technologies, litigation outcomes are unpredictable or there may be changes in our litigation strategy. These statements are based on management's current expectations, forecasts, beliefs, assumptions and information currently available to management. Actual outcomes and results could differ materially from these statements due to a number of factors and such statements should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. The material risks and uncertainties that could affect 10x Genomics, Inc.'s financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's most recently-filed 10-K for the fiscal year ended December 31, 2023 and elsewhere in the documents 10x Genomics, Inc. files with the Securities and Exchange Commission from time to time. Disclosure Information 10x Genomics uses filings with the Securities and Exchange Commission, our website ( www.10xgenomics.com ), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Contacts Investors: investors@10xgenomics.com Media: media@10xgenomics.com View original content to download multimedia: https://www.prnewswire.com/news-releases/us-district-court-awards-10x-genomics-permanent-injunction-in-patent-infringement-lawsuit-against-bruker-corporations-geomx-products-302338627.html SOURCE 10x Genomics, Inc.Harris Dickinson was nervous to approach Nicole Kidman . This would not necessarily be notable under normal circumstances, but the English actor had already been cast to star opposite her in the erotic drama “Babygirl,” as the intern who initiates an affair with Kidman's buttoned-up CEO. They’d had a zoom with the writer-director Halina Reijn, who was excited by their playful banter and sure that Dickinson would hold his own. And yet when he found himself at the same event as Kidman, shyness took over. He admitted as much to Margaret Qualley, who took things into her own hands and introduced them. “She helped me break the ice a bit,” Dickinson said in a recent interview with The Associated Press. On set would be an entirely different story. Dickinson might not be nearly as “puckishly audacious” as his character Samuel but in the making of “Babygirl,” he, Kidman and Reijn had no choice but to dive fearlessly into this exploration of sexual power dynamics, going to intimate, awkward, exhilarating and meme-able places. It’s made the film, in theaters Christmas Day, one of the year’s must-sees. “There was an unspoken thing that we adhered to,” Dickinson said. “We weren’t getting to know each other’s personal lives. When we were working and we were the characters, we didn’t veer away from the material. I never tried to attach all of the history of Nicole Kidman. Otherwise it probably would have been a bit of a mess.” His is a performance that reconfirms what many in the film world have suspected since his debut seven years ago as a Brooklyn tough questioning his sexuality in Eliza Hittman’s “Beach Rats” : Dickinson is one of the most exciting young talents around. Dickinson, 28, grew up in Leytonstone, in East London — the same neck of the woods as Alfred Hitchcock. Cinema was in his life, whether it was Christopher Nolan’s “Batman” films at the local multiplex or venturing into town to see the more social realist films of Mike Leigh and Ken Loach. “Working class cinema interested me,” he said. “People around me that represented my world.” Appropriately, his entry into making art started behind the camera, with a comedy web series he made as a kid, which he now describes as “really bad spoofs” of films and shows of the time. But things started to really click when he began acting in the local theater. “I remember feeling invigorated by it and accepted,” he said. “I felt myself for the first time and felt able to express myself in a way where I didn’t feel vulnerable and I felt alive and ignited by something.” At around 17, someone suggested that he should give acting a try professionally. He hadn’t even fully understood that it was a career possibility, but he started auditioning. At 20, he was cast in “Beach Rats” and, he said, just “kept going.” Since then, he’s gotten a wide range of opportunities in films both big, including “The King’s Man,” and small. He’s captivated as a male model in Ruben Östlund’s Cannes-winning “Triangle of Sadness,” an estranged father to a 12-year-old in Charlotte Regan’s “Scrapper,” an actor bringing an ex-boyfriend to life in Joanna Hogg’s “The Souvenir Part II,” the charismatic, tragic wrestler David Von Erich in Sean Durkin’s “The Iron Claw” and a soldier in Steve McQueen’s “Blitz.” But “Babygirl” would present new challenges and opportunities with a character who’s almost impossible to define. “He was confusing in a really interesting way. There wasn’t loads of specificity to it, which I enjoyed because it was a bit of a challenge to sort of pinpoint exactly what it was that drove him and made him tick,” Dickinson said. “There was a directness that unlocked a lot for me, like a fearlessness with the way he spoke, or a social unawareness in a way — like not fully realizing what he’s saying is affecting someone in a certain way. But I didn’t make too many rules for him.” Part of the allure of the film is the ever-shifting power dynamics between the two characters, which could change over the course of a scene. As Reijn said, “It’s a cautionary tale about what happens when you suppress your own desires.” She was especially in awe of Dickinson's ability to make everything feel improvised and the fact that he could look like a 12-year-old boy in one shot and a confident 45-year-old man in the next. Since its premiere at the Venice Film Festival earlier this year, the film has led to some surprisingly direct conversations with audiences spanning generations. But that, Dickinson understood, was what Reijn wanted. “She really wanted to show the ugliness and the awkwardness of these things, of these relationships and sex,” he said. “That sort of fumbly version and the performative version of it is way more interesting, to me at least, than the kind of fantasized, romanticized, sexy thing that we’ve seen a lot.” Dickinson recently stepped behind the camera again, directing his first feature film under the banner of his newly formed production company. Set against the backdrop of homelessness in London, “Dream Space” is about a drifter trying to assimilate and understand his cyclical behavior. The film, which wrapped earlier this year, has given him a heightened appreciation for just how many people are indispensable in the making of a film. He’s also started to understand that “acting is just being able to relax.” “When you’re relaxed, you can do stuff that is truthful,” he said. “That only happens if you’ve got good people around you: The director that creates the good environment. The intimacy coordinator facilitating a safe space. A coworker in Nicole encouraging that kind of bravery and performance with what she’s doing.” Dickinson did eventually get to the point where he managed to ask Kidman questions about working with Stanley Kubrick and Lars Von Trier. But he also kept one shattering possibility between himself and his director. “There is a world in which Samuel doesn’t even exist. He’s just a sort of a device or a figment for her own story. And I like that because it kind of means you can take the character into a very unrealistic realm at times and be almost like a deity in the story,” Dickinson said. “We didn’t talk about it with Nicole.” Lindsey Bahr, The Associated Press